Page last updated: 2024-09-04

tecadenoson and Tachycardia, Supraventricular

tecadenoson has been researched along with Tachycardia, Supraventricular in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albrecht-Küpper, B; Dinh, W; Gheorghiade, M; Sabbah, HN; van der Laan, M; Voors, AA	1
Beharier, O; Dror, S; Etzion, Y; Katz, A; Mor, M; Moran, A; Pikovsky, O; Shalev, A	1
Bahnson, T; Belardinelli, L; Bloomfield, DM; Curtis, AB; Dhala, A; Ellenbogen, K; Fogel, RI; Gold, M; Gonzalez, MD; Kadish, A; Niazi, I; Prystowsky, EN; Shreeniwas, R; Wilber, DJ; Wolff, AA	1
Cheung, JW; Lerman, BB	1
Belardinelli, L; Camm, JA; Ellenbogen, KA; Jerling, M; Lieu, HD; Meng, L; O'Neill, G; Prystowsky, EN; Shreeniwas, R; Wolff, AA	1

Reviews

2 review(s) available for tecadenoson and Tachycardia, Supraventricular

Article	Year
Partial Adenosine A1 Agonist in Heart Failure. Handbook of experimental pharmacology, 2017, Volume: 243 Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles	2017
CVT-510: a selective A1 adenosine receptor agonist. Cardiovascular drug reviews, 2003,Winter, Volume: 21, Issue:4 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Furans; Heart Rate; Humans; Receptor, Adenosine A1; Tachycardia, Supraventricular	2003

Article

Year

Partial Adenosine A1 Agonist in Heart Failure.

Handbook of experimental pharmacology, 2017, Volume: 243

Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles

2017

CVT-510: a selective A1 adenosine receptor agonist.

Cardiovascular drug reviews, 2003,Winter, Volume: 21, Issue:4

Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Furans; Heart Rate; Humans; Receptor, Adenosine A1; Tachycardia, Supraventricular

2003

Trials

2 trial(s) available for tecadenoson and Tachycardia, Supraventricular

Article	Year
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist. Journal of the American College of Cardiology, 2003, Sep-17, Volume: 42, Issue:6 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Female; Furans; Humans; Male; Middle Aged; Purinergic P1 Receptor Agonists; Remission Induction; Tachycardia, Paroxysmal; Tachycardia, Supraventricular	2003
Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson. Circulation, 2005, Jun-21, Volume: 111, Issue:24 Topics: Adenosine; Adenosine A1 Receptor Agonists; Adult; Aged; Blood Pressure; Disease Management; Dose-Response Relationship, Drug; Double-Blind Method; Electrophysiology; Female; Furans; Heart Arrest; Heart Rate; Humans; Male; Middle Aged; Pericardial Effusion; Syncope; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Venous Thrombosis	2005

Article

Year

Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.

Journal of the American College of Cardiology, 2003, Sep-17, Volume: 42, Issue:6

Topics: Adenosine; Adult; Aged; Aged, 80 and over; Female; Furans; Humans; Male; Middle Aged; Purinergic P1 Receptor Agonists; Remission Induction; Tachycardia, Paroxysmal; Tachycardia, Supraventricular

2003

Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.

Circulation, 2005, Jun-21, Volume: 111, Issue:24

Topics: Adenosine; Adenosine A1 Receptor Agonists; Adult; Aged; Blood Pressure; Disease Management; Dose-Response Relationship, Drug; Double-Blind Method; Electrophysiology; Female; Furans; Heart Arrest; Heart Rate; Humans; Male; Middle Aged; Pericardial Effusion; Syncope; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Venous Thrombosis

2005

Other Studies

1 other study(ies) available for tecadenoson and Tachycardia, Supraventricular

Article	Year
INO-8875, a highly selective A1 adenosine receptor agonist: evaluation of chronotropic, dromotropic, and hemodynamic effects in rats. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1 Topics: Adenosine; Adenosine A1 Receptor Agonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Dose-Response Relationship, Drug; Furans; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Male; Nitrates; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Tachycardia, Supraventricular	2013

Article

Year

INO-8875, a highly selective A1 adenosine receptor agonist: evaluation of chronotropic, dromotropic, and hemodynamic effects in rats.

The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1

Topics: Adenosine; Adenosine A1 Receptor Agonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Dose-Response Relationship, Drug; Furans; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Male; Nitrates; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Tachycardia, Supraventricular

2013